DiMartino's most recent trade in BNY Mellon High Yield Strategies Fund was a trade of 10,000 Shares of Beneficial Interest, Par Value $.001 per share done at an average price of $2.4 . Disclosure was reported to the exchange on April 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BNY Mellon High Yield Stra... | Joseph S. DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 04 Apr 2025 | 10,000 | 210,000 (0%) | 0% | 2.4 | 23,771 | Shares of Beneficial Interest, Par Value $.001 per share |
| BNY Mellon High Yield Stra... | Joseph S. DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 2.32 per share. | 04 Apr 2025 | 10,000 | 220,000 (0%) | 0% | 2.3 | 23,200 | Shares of Beneficial Interest, Par Value $.001 per share |
| abrdn Japan Equity Fund Inc | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 6.19 per share. | 02 Oct 2024 | 1,000 | 1,000 (0%) | 0% | 6.2 | 6,190 | Common Stock |
| Tekla Healthcare Investors | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 18.88 per share. | 16 Jul 2024 | 1,000 | 1,000 (0%) | 0% | 18.9 | 18,880 | Common Stock |
| Tekla Life Sciences Investors | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 15.53 per share. | 16 Jul 2024 | 1,000 | 1,000 (0%) | 0% | 15.5 | 15,530 | Common Stock |
| Tekla Healthcare Opportuni... | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 21.30 per share. | 16 Jul 2024 | 1,000 | 1,000 (0%) | 0% | 21.3 | 21,300 | Common Stock |
| Tekla World Healthcare Fund | Rose DiMartino | Director | Purchase of securities on an exchange or from another person at price $ 13.31 per share. | 16 Jul 2024 | 1,000 | 1,000 (0%) | 0% | 13.3 | 13,310 | Common Stock |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 04 Jan 2024 | 12,009 | 315,246 | - | 1.2 | 14,214 | Common Stock |
| Kronos Bio Inc | DiMartino Jorge | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 12 Dec 2023 | 17,367 | 327,255 | - | 1.3 | 22,664 | Common Stock |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 06 Jul 2023 | 10,818 | 344,622 | - | 1.8 | 18,956 | Common Stock |
| Cbiz Inc | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 52.35 per share. | 05 Jun 2023 | 5,000 | 15,999 (0%) | 0% | 52.3 | 261,748 | Common Stock |
| Cbiz Inc | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 50.39 per share. | 19 May 2023 | 4,873 | 20,999 (0%) | 0% | 50.4 | 245,572 | Common Stock |
| Cbiz Inc | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 49.74 per share. | 15 May 2023 | 5,000 | 30,872 (0%) | 0% | 49.7 | 248,676 | Common Stock |
| Cbiz Inc | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 50.28 per share. | 15 May 2023 | 5,000 | 25,872 (0%) | 0% | 50.3 | 251,394 | Common Stock |
| Cbiz Inc | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 49.91 per share. | 15 May 2023 | 5,000 | 35,872 (0%) | 0% | 49.9 | 249,567 | Common Stock |
| Intuitive Surgical | Michele DiMartino | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 4,668 | 4,668 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | Michele DiMartino | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 3,112 | 3,112 | - | - | Restricted Stock Units | |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.74 per share. | 24 Feb 2023 | 10,153 | 355,440 | - | 1.7 | 17,621 | Common Stock |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 205,513 | 205,513 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 137,008 | 365,593 | - | 0 | Common Stock | |
| Intuitive Surgical | Michele DiMartino | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,504 | 1,901 (0%) | 0% | - | Common Stock | |
| Intuitive Surgical | Michele DiMartino | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 1,504 | 0 | - | - | Restricted Stock Units | |
| Intuitive Surgical | Michele DiMartino | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 987 | 2,410 (0%) | 0% | - | Common Stock | |
| Intuitive Surgical | Michele DiMartino | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 987 | 2,960 | - | - | Restricted Stock Units | |
| Intuitive Surgical | Michele DiMartino | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.27 per share. | 10 Feb 2023 | 478 | 1,423 (0%) | 0% | 245.3 | 117,239 | Common Stock |
| Intuitive Surgical | Michele DiMartino | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.27 per share. | 10 Feb 2023 | 298 | 2,112 (0%) | 0% | 245.3 | 73,090 | Common Stock |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 12 Dec 2022 | 18,657 | 219,478 | - | 1.8 | 33,680 | Common Stock |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 60,300 | 238,135 | - | 0 | Common Stock | |
| Cbiz Inc | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 40.71 per share. | 26 May 2022 | 1,000 | 41,872 (0%) | 0% | 40.7 | 40,708 | Common Stock |
| Cbiz Inc | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 41.33 per share. | 26 May 2022 | 1,000 | 40,872 (0%) | 0% | 41.3 | 41,334 | Common Stock |
| Cbiz Inc | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 38.39 per share. | 23 May 2022 | 2,749 | 42,872 (0%) | 0% | 38.4 | 105,534 | Common Stock |
| Cbiz Inc | Joseph S. DiMartino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 3,004 | 45,621 (0%) | 0% | 0 | Common Stock | |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 60,300 | 177,835 | - | 0 | Common Stock | |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 13 Dec 2021 | 16,152 | 117,785 | - | 12.4 | 199,687 | Common Stock |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Sale of securities on an exchange or to another person at price $ 12.82 per share. | 13 Dec 2021 | 250 | 117,535 | - | 12.8 | 3,206 | Common Stock |
| Cbiz Inc | DiMartino | Director | Sale of securities on an exchange or to another person at price $ 34.48 per share. | 17 May 2021 | 5,933 | 42,617 (0%) | 0% | 34.5 | 204,556 | Common Stock |
| Cbiz Inc | DiMartino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 3,738 | 48,550 (0%) | 0% | 0 | Common Stock | |
| BNY Mellon High Yield Stra... | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 06 Jan 2021 | 50,000 | 200,000 (0%) | 0% | 3.0 | 147,500 | Shares of Beneficial Interest, Par Value $.001 per share |
| BNY Mellon High Yield Stra... | Joseph S. DiMartino | Director | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 06 Jan 2021 | 20,000 | 250,000 (0%) | 0% | 3.0 | 59,018 | Shares of Beneficial Interest, Par Value $.001 per share |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 200,906 | 200,906 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Jorge DiMartino | Chief Medical Officer & VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 133,937 | 133,937 | - | 0 | Common Stock |